Summary
Ameriprise Financial, Inc. filed an 8-K report on April 26, 2024, detailing key outcomes from its 2024 annual shareholder meeting held on April 24, 2024. The most significant development for investors is the shareholder approval of an amendment to the company's Certificate of Incorporation. This amendment, effective upon filing with the Delaware Secretary of State, permits the exculpation of corporate officers, subject to certain limitations as allowed by recent changes in Delaware law. This move is intended to provide greater protection to the company's leadership from personal liability for certain actions. Additionally, the meeting saw the election of all eight director nominees, confirming the current board's composition for the upcoming year. Shareholders also provided advisory approval for the compensation of named executive officers and ratified the selection of PricewaterhouseCoopers LLP as the company's independent registered public accounting firm for 2024. These outcomes reflect shareholder confidence in the company's governance and oversight.
Key Highlights
- 1Shareholders approved an amendment to the Certificate of Incorporation to allow exculpation of corporate officers, subject to limitations permitted by Delaware law.
- 2All eight director nominees were elected to serve a one-year term expiring at the 2025 annual meeting.
- 3Shareholders provided advisory approval for the compensation of the company's named executive officers.
- 4The selection of PricewaterhouseCoopers LLP as the independent registered public accounting firm for 2024 was ratified.
- 5The 2024 annual shareholder meeting saw strong participation, with approximately 87.86% of outstanding shares represented.
- 6The Charter Amendment permitting officer exculpation was filed with the Delaware Secretary of State on April 25, 2024, and became effective upon filing.